{ "cik": 1267565, "cik_padded": "0001267565", "entityName": "COLLEGIUM PHARMACEUTICAL, INC", "fiscal_years": [ { "accn": "0001628280-26-011992", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 25104000.0, "capex": 1740000.0, "cash": 231252000.0, "cost_of_revenue": 317310000.0, "eps_diluted": 1.73, "free_cash_flow": 327583000.0, "gross_profit": 463257000.0, "net_income": 62870000.0, "operating_cash_flow": 329323000.0, "operating_income": 179636000.0, "revenue": 780567000.0, "stockholders_equity": 301675000.0, "total_assets": 1656834000.0, "total_liabilities": 1355159000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5934878107836995, "leverage": 4.49211568741195, "net_margin": 0.08054401479949831, "operating_margin": 0.23013527346147092, "revenue_growth_yoy": 0.2361520882921661, "roa_avg2y": 0.03786864633292425, "roa_period_end": 0.037945865427677125, "roe_avg2y": 0.2370140824893453, "roe_period_end": 0.20840308278776828 } }, { "accn": "0001628280-26-011992", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 60025000.0, "capex": 1652000.0, "cash": 70565000.0, "cost_of_revenue": 254105000.0, "eps_diluted": 1.86, "free_cash_flow": 203328000.0, "gross_profit": 377344000.0, "net_income": 69190000.0, "operating_cash_flow": 204980000.0, "operating_income": 169895000.0, "revenue": 631449000.0, "stockholders_equity": 228842000.0, "total_assets": 1663591000.0, "total_liabilities": 1434749000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5975842863002396, "leverage": 6.269605229809214, "net_margin": 0.10957337805586832, "operating_margin": 0.2690557748923508, "revenue_growth_yoy": 0.11412449913280061, "roa_avg2y": 0.04929995699880901, "roa_period_end": 0.041590751572952736, "roe_avg2y": 0.32615792190405707, "roe_period_end": 0.3023483451464329 } }, { "accn": "0001628280-26-011992", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 75000000.0, "capex": 461000.0, "cash": 238947000.0, "cost_of_revenue": 240598000.0, "eps_diluted": 1.29, "free_cash_flow": 274288000.0, "gross_profit": 326169000.0, "net_income": 48155000.0, "operating_cash_flow": 274749000.0, "operating_income": 166961000.0, "revenue": 566767000.0, "stockholders_equity": 195431000.0, "total_assets": 1143308000.0, "total_liabilities": 947877000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5754904572778584, "leverage": 4.850187534219239, "net_margin": 0.08496436807365285, "operating_margin": 0.2945848999677116, "revenue_growth_yoy": 0.22165700650740516, "roa_avg2y": 0.04155880694162824, "roa_period_end": 0.0421190090509294, "roe_avg2y": 0.2467759747663815, "roe_period_end": 0.2464041017034145 } }, { "accn": "0001628280-26-011992", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 14063000.0, "capex": 1622000.0, "cash": 173688000.0, "cost_of_revenue": 254445000.0, "eps_diluted": -0.74, "free_cash_flow": 122608000.0, "gross_profit": 209488000.0, "net_income": -25002000.0, "operating_cash_flow": 124230000.0, "operating_income": 33319000.0, "revenue": 463933000.0, "stockholders_equity": 194842000.0, "total_assets": 1174131000.0, "total_liabilities": 979289000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.4515479605891368, "leverage": 5.0260672750228395, "net_margin": -0.053891402422332535, "operating_margin": 0.07181856000758731, "revenue_growth_yoy": 0.6756468786569774, "roa_avg2y": -0.026794440919768858, "roa_period_end": -0.021294046405384067, "roe_avg2y": -0.12571083792141188, "roe_period_end": -0.12831935619630264 } }, { "accn": "0001558370-25-001801", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 47861000.0, "capex": 1944000.0, "cash": 186426000.0, "cost_of_revenue": 126251000.0, "eps_diluted": 1.86, "free_cash_flow": 101613000.0, "gross_profit": 150617000.0, "net_income": 71517000.0, "operating_cash_flow": 103557000.0, "operating_income": 17628000.0, "revenue": 276868000.0, "stockholders_equity": 202928000.0, "total_assets": 692077000.0, "total_liabilities": 489149000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5440029183582068, "leverage": 2.4104559252542774, "net_margin": 0.2583072077668781, "operating_margin": 0.06366932978892469, "revenue_growth_yoy": -0.10692351362510322, "roa_avg2y": 0.10706794878128748, "roa_period_end": 0.10333676744061716, "roe_avg2y": 0.36773541684342054, "roe_period_end": 0.35242549081447605 } }, { "accn": "0001558370-24-001526", "filed": "2024-02-22", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5546000.0, "cash": 174116000.0, "cost_of_revenue": 130180000.0, "eps_diluted": 0.76, "free_cash_flow": 88396000.0, "gross_profit": 179836000.0, "net_income": 26752000.0, "operating_cash_flow": 93942000.0, "operating_income": 56232000.0, "revenue": 310016000.0, "stockholders_equity": 186031000.0, "total_assets": 643841000.0, "total_liabilities": 457810000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5800861890999174, "leverage": 2.460933930366444, "net_margin": 0.08629232039636664, "operating_margin": 0.1813841866226259, "revenue_growth_yoy": 0.04487682886137896, "roa_avg2y": 0.05631152363381091, "roa_period_end": 0.041550631289402194, "roe_avg2y": 0.19565352533980832, "roe_period_end": 0.14380398965763772 } }, { "accn": "0001558370-23-001900", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6438000.0, "cash": 170019000.0, "cost_of_revenue": 193660000.0, "eps_diluted": -0.68, "free_cash_flow": 21345000.0, "gross_profit": 103041000.0, "net_income": -22722000.0, "operating_cash_flow": 27783000.0, "operating_income": -23748000.0, "revenue": 296701000.0, "stockholders_equity": 87432000.0, "total_assets": 306302000.0, "total_liabilities": 218870000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.3472890216076117, "leverage": 2.503316863390978, "net_margin": -0.07658214835811136, "operating_margin": -0.08004017512580004, "revenue_growth_yoy": 0.058085752087100095, "roa_avg2y": -0.07605092151747059, "roa_period_end": -0.07418168996611188, "roe_avg2y": -0.25385298602925976, "roe_period_end": -0.25988196541312103 } }, { "accn": "0001558370-22-001927", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 5477000.0, "cash": 146633000.0, "cost_of_revenue": 165677000.0, "eps_diluted": -1.19, "free_cash_flow": 163913000.0, "gross_profit": 114736000.0, "net_income": -39128000.0, "operating_cash_flow": 169390000.0, "operating_income": -20685000.0, "revenue": 280413000.0, "stockholders_equity": 91585000.0, "total_assets": 291245000.0, "total_liabilities": 199660000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.409167905910211, "leverage": 2.180051318447344, "net_margin": -0.1395370400088441, "operating_margin": -0.0737661948625777, "revenue_growth_yoy": 8.847345132743364, "roa_avg2y": -0.1833496168111093, "roa_period_end": -0.13434737077031364, "roe_avg2y": -0.39994889223928654, "roe_period_end": -0.4272315335480701 } }, { "accn": "0001558370-20-001625", "filed": "2020-02-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 990000.0, "cash": 118697000.0, "free_cash_flow": -68008000.0, "net_income": -74865000.0, "operating_cash_flow": -67018000.0, "operating_income": -75447000.0, "revenue": 28476000.0, "stockholders_equity": 104080000.0, "total_assets": 135568000.0, "total_liabilities": 31488000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.30253651037663337, "revenue_growth_yoy": 15.642898889538282, "roa_avg2y": -0.5031503604012298, "roa_period_end": -0.5522320901687714, "roe_avg2y": -0.6265168125596264, "roe_period_end": -0.7193024596464258 } }, { "accn": "0001558370-19-001187", "filed": "2019-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 477000.0, "cash": 153225000.0, "free_cash_flow": -75530000.0, "net_income": -94176000.0, "operating_cash_flow": -75053000.0, "operating_income": -94082000.0, "revenue": 1711000.0, "stockholders_equity": 134908000.0, "total_assets": 162017000.0, "total_liabilities": 27109000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.20094434725887272, "roa_period_end": -0.5812723356191017, "roe_period_end": -0.6980757256797224 } } ], "latest_filing": { "accn": "0001628280-26-011992", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001267565.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001267565.json" }, "ticker": "COLL" }